I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Alizadeh Aghdam, Mehran
32
results:
Search for persons
X
Format
Online (32)
Mediatypes
Articles (Online) (21)
OpenAccess-fulltext (11)
Sorted by: Relevance
Sorted by: Year
?
1
Clinical profile of idiopathic angioedema based on severity..:
Soegiharto, Reineke
;
Alizadeh Aghdam, Mehran
;
Knulst, Andre C.
.
JEADV Clinical Practice. 2 (2023) 1 - p. 114-121 , 2023
Link:
https://doi.org/10.1002/..
?
2
Age and fast initial response predict omalizumab retreatmen..:
Meertens, Michelle A.J.
;
Luijf, Teddy
;
van Lindonk, Esmee A.M.
...
The Journal of Allergy and Clinical Immunology: In Practice. 11 (2023) 11 - p. 3556-3558.e1 , 2023
Link:
https://doi.org/10.1016/..
?
3
Recombinant human C1 esterase inhibitor as prophylactic tre..:
Alizadeh Aghdam, Mehran
;
Hofman, Zonne L. M.
;
Meertens, Michelle
...
Allergy. 77 (2022) 12 - p. 3673-3676 , 2022
Link:
https://doi.org/10.1111/..
?
4
Safety and effectiveness of omalizumab for the treatment of..:
Dekkers, Coco
;
Alizadeh Aghdam, Mehran
;
de Graaf, Marlies
...
Pediatric Allergy and Immunology. 32 (2021) 4 - p. 720-726 , 2021
Link:
https://doi.org/10.1111/..
?
5
Systemic and local evidence for complement involvement in c..:
Alizadeh Aghdam, Mehran
;
van den Elzen, Mignon
;
van Os‐Medendorp, Harmieke
...
Clinical and Translational Allergy. 11 (2021) 5 - p. , 2021
Link:
https://doi.org/10.1002/..
?
6
Effective omalizumab interval prolongation in the treatment..:
Alizadeh Aghdam, Mehran
;
Pieterse, Rianne Henriëtte
;
Kentie, Petra Adriana
...
The Journal of Allergy and Clinical Immunology: In Practice. 8 (2020) 10 - p. 3667-3668.e1 , 2020
Link:
https://doi.org/10.1016/..
?
7
Response of FcεRI‐bearing leucocytes to omalizumab in chron..:
Alizadeh Aghdam, Mehran
;
Knol, Edward F.
;
van den Elzen, Mignon
...
Clinical & Experimental Allergy. 50 (2020) 3 - p. 364-371 , 2020
Link:
https://doi.org/10.1111/..
?
8
A Comparison of Visual Recognition of the Laryngopharyngeal..:
Aghdam, Mehran Alizadeh
;
Ogawa, Makoto
;
Iwahashi, Toshihiko
...
Dysphagia. 32 (2017) 5 - p. 617-625 , 2017
Link:
https://doi.org/10.1007/..
?
9
Treatment optimisation in chronic urticaria and angioedema:
Alizadeh Aghdam, Mehran
https://dspace.library.uu.nl/handle/1874/432393. , 2023
Link:
https://dspace.library.u..
?
10
Recombinant human C1 esterase inhibitor as prophylactic tre..:
Alizadeh Aghdam, Mehran
;
Hofman, Zonne L. M
;
Meertens, Michelle
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084080/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Safety and effectiveness of omalizumab for the treatment of..:
Dekkers, Coco
;
Alizadeh Aghdam, Mehran
;
de Graaf, Marlies
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248194/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
12
Systemic and local evidence for complement involvement in c..:
Alizadeh Aghdam, Mehran
;
van den Elzen, Mignon
;
van Os‐Medendorp, Harmieke
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254579/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
13
Response of FcεRI‐bearing leucocytes to omalizumab in chron..:
Alizadeh Aghdam, Mehran
;
Knol, Edward F
;
van den Elzen, Mignon
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065003/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
14
Clinical profile of idiopathic angioedema based on severity..:
Reineke Soegiharto
;
Mehran Alizadeh Aghdam
;
Andre C. Knulst
.
https://doi.org/10.1002/jvc2.103. , 2023
Link:
https://doi.org/10.1002/..
?
15
Systemic and local evidence for complement involvement in c..:
Mehran Alizadeh Aghdam
;
Mignon van den Elzen
;
Harmieke van Os‐Medendorp
...
https://doi.org/10.1002/clt2.12011. , 2021
Link:
https://doi.org/10.1002/..
1-15
